Antisense oligodeoxynucleotides as specific tools for studying neuroendocrine and behavioral functions: some prospects and problems (Q41449985)

30 September 2017

1 reference

title

Antisense oligodeoxynucleotides as specific tools for studying neuroendocrine and behavioral functions: some prospects and problems (English)

1 reference

30 September 2017

Nicot A

1

1 reference

PubMed ID

9125374

30 September 2017

Pfaff DW

series ordinal

2

1 reference

30 September 2017

1 January 1997

1 reference

Journal of Neuroscience Methods

30 September 2017

1 reference

30 September 2017

71

1 reference

30 September 2017

1

1 reference

30 September 2017

45-53

1 reference

Specific inhibition of endogenous neuropeptide Y synthesis in arcuate nucleus by antisense oligonucleotides suppresses feeding behavior and insulin secretion.

30 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and sera

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

Cellular uptake and intracellular fate of antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

Basic local alignment search tool

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

Inhibition of translation initiation by antisense oligonucleotides via an RNase-H independent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

Opioid peptide receptor studies. 4. Antisense oligodeoxynucleotide to the delta opioid receptor delineates opioid receptor subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

Antisense oligonucleotide eliminates in vivo expression of c-fos in mammalian brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

The application of antisense oligonucleotide technology to the brain: some pitfalls

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

Sequence complexity of nuclear RNAs in adult rat tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

Complexity of cytoplasmic polyadenylated and nonpolyadenylated rat brain ribonucleic acids

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

RNase H cleavage of RNA hybridized to oligonucleotides containing methylphosphonate, phosphorothioate and phosphodiester bonds

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

In vivo antisense inhibition of prodynorphin expression in rat striatum: dose-dependence and sequence specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

Antisense inhibition of AT1 receptor mRNA and angiotensinogen mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

Specific regulation of gene expression by antisense, sense and antigene nucleic acids

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

Central administration of antisense oligodeoxynucleotides to neuropeptide Y (NPY) mRNA reveals the critical role of newly synthesized NPY in regulation of LHRH release

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

V1 vasopressin receptor antisense oligodeoxynucleotide into septum reduces vasopressin binding, social discrimination abilities, and anxiety-related behavior in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

Inhibition of rat sexual behavior by antisense oligonucleotides to the progesterone receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

Techniques for using antisense oligodeoxyribonucleotides to study gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

Intracerebral administration of antisense oligodeoxynucleotides to GAD65 and GAD67 mRNAs modulate reproductive behavior in the female rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

Infusion of antisense oligodeoxynucleotides to the oxytocin receptor in the ventromedial hypothalamus reduces estrogen-induced sexual receptivity and oxytocin receptor binding in the female rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

Antisense vasopressin oligonucleotides: uptake, turnover, distribution, toxicity and behavioral effects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

Antisense oligonucleotides in the study of neuroendocrine systems

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

Central oxytocin mediates stress-induced tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

Site and mechanism of antisense inhibition by C-5 propyne oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

Acute, sequence-specific effects of oxytocin and vasopressin antisense oligonucleotides on neuronal responses

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

Effects of intrahypothalamic administration of antisense DNA for progesterone receptor mRNA on reproductive behavior and progesterone receptor immunoreactivity in female rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

Cellular uptake of intracerebrally administered oligodeoxynucleotides in mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

Antisense oligonucleotide blocks progesterone-induced lordosis behavior in ovariectomized rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

Intracerebroventricular administration of AT1 receptor antisense oligonucleotides inhibits the behavioral actions of angiotensin II.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

Antisense inhibition of low-affinity nerve growth factor receptor in kidney cultures: power and pitfalls.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

Vasopressin antisense oligonucleotide induces temporary diabetes insipidus in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

Selective loss of delta opioid analgesia and binding by antisense oligodeoxynucleotides to a delta opioid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

Antisense oligodeoxynucleotides to the cloned delta receptor DOR-1: uptake, stability, and regulation of gene expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

Phosphorothioate and normal oligodeoxyribonucleotides with 5'-linked acridine: characterization and preliminary kinetics of cellular uptake

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

Antisense oligodeoxyribonucleotides: stability and distribution after intracerebral injection into rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

Antisense gene inhibition by oligonucleotides containing C-5 propyne pyrimidines

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

Antisense oligonucleotide strategies in neuropharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

Specificity of antisense oligonucleotides in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2896%2900125-2

7 January 2021

10.1016/S0165-0270(96)00125-2

Identifiers

DOI

1 reference

release_slhqjmoqa5buhfhuvkrgjcj2tu

30 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/slhqjmoqa5buhfhuvkrgjcj2tu

24 November 2022

mapped directly with Wikidata item

PubMed ID

9125374

1 reference

PubMed ID

9125374